Stockreport

Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

Tvardi Therapeutics, Inc.  (TVRD) 
PDF HOUSTON--(BUSINESS WIRE)--Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral s [Read more]